dithiothreitol has been researched along with (2-sulfonatoethyl)methanethiosulfonate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ball, SG; Balmforth, AJ; Fearon, IM; Palmer, AC; Peers, C; Varadi, G | 1 |
Haddrill, J; Han, NL; Lynch, JW; Pierce, KD; Schofield, PR | 1 |
Alexander, C; Borg, E; Dawson, DC; Liu, X; Serrano, J | 1 |
3 other study(ies) available for dithiothreitol and (2-sulfonatoethyl)methanethiosulfonate
Article | Year |
---|---|
Hypoxic and redox inhibition of the human cardiac L-type Ca2+ channel.
Topics: 4-Chloromercuribenzenesulfonate; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Hypoxia; Cell Line; Dithiothreitol; Ethyl Methanesulfonate; Humans; Mesylates; Myocardium; Oxidation-Reduction; Recombinant Proteins; Transfection | 2000 |
The surface accessibility of the glycine receptor M2-M3 loop is increased in the channel open state.
Topics: Amino Acid Substitution; Cell Line; Cysteine; Dithiothreitol; Dose-Response Relationship, Drug; Glycine; Humans; Ion Channel Gating; Kidney; Mesylates; Mutagenesis, Site-Directed; Patch-Clamp Techniques; Protein Binding; Protein Conformation; Receptors, Glycine; Reducing Agents; Reflex, Startle; Transfection | 2001 |
Variable reactivity of an engineered cysteine at position 338 in cystic fibrosis transmembrane conductance regulator reflects different chemical states of the thiol.
Topics: Alkylating Agents; Animals; Catalysis; Copper; Cysteine; Cystic Fibrosis Transmembrane Conductance Regulator; Disulfides; Dithiothreitol; Glutathione; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Iodoacetamide; Mercaptoethanol; Mesylates; Metals; Models, Biological; Oocytes; Oxygen; Phenotype; Protein Engineering; Sulfhydryl Compounds; Sulfinic Acids; Sulfonic Acids; Time Factors; Xenopus | 2006 |